For the Culture By The Culture
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
The San Francisco Chronicle’s new article warns that cannabis is dangerous for older adults, but the science says otherwise. Studies show benefits for pain, sleep, and muscle spasticity when used responsibly. The real risk comes from misinformation, fear, and the unregulated hemp market, not from seniors using cannabis with care.
Delays, raids, and vetoes mar a week already full of weed whiplash, but home growers in Connecticut finally get a win. From the FDA’s excuses to Tyson’s plea for federal legalization, Pot Culture Magazine cuts through the noise and grades the week’s cannabis chaos in Volume 07 of Reefer Report Card.
Hemp-derived THC drinks are flooding the market as cannabis companies exploit legal gray areas following the 2018 Farm Bill. Major players like Trulieve and Curaleaf are bypassing dispensary regulations and taxation to deliver these products directly to consumers. This trend is creating irony for lawmakers while providing new legal options for the public.
In a historic move, the U.S. Justice Department proposes reclassifying marijuana from a Schedule One to a Schedule Three drug. This shift could open doors to more research and investment in the cannabis sector, aligning federal laws closer to state realities.
©2024PotCultureMagazine/ArtDept. Venturing into the realm of medical treatment with psychedelic substances is like navigating a labyrinth, and the latest saga with MDMA's journey towards FDA approval is no exception. This mind-bending tale begins with the Food and Drug Administration's scrutiny of clinical trials for MDMA, popularly known as ecstasy, for treating post-traumatic stress disorder (PTSD).... Continue Reading →
